Oxaliplatin has been evaluated in numerous clinical trials assessing its efficacy in gastrointestinal malignancies—including colorectal, pancreatic, gastric, esophageal, and biliary tract cancers—germ cell tumors, and treatment-associated neuropathy. Spanning Early Phase 1 through Phase 3, these active, recruiting, and completed studies focus on oxaliplatin-based combination regimens. This research is supported by academic medical centers, cooperative oncology networks, and organizations such as the National Cancer Institute, Dartmouth-Hitchcock Medical Center, and GERCOR.
| NCT Number | Recruitment | Conditions | Sponsor/Collaborators | Start Date | Phases |
|---|---|---|---|---|---|
| NCT06780111 | RECRUITING | Esophageal Squamous Cell Carcinoma |
Merck Sharp & Dohme LLC |
2025-07-30 | PHASE1; PHASE2 |
| NCT06839092 | NOT_YET_RECRUITING | Colorectal Cancer Control and Prevention; Colorectal Cancer; Colorectal Cancer Stage II; Colorectal Cancer Stage III |
Jeremy Meyer |
2026-01 | PHASE3 |
| NCT07643623 | RECRUITING | Resectable Gastric/Gastroesophageal Junction Adenocarcinoma |
Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD. |
2026-07-31 | PHASE2; PHASE3 |
| NCT07772557 | NOT_YET_RECRUITING | Gastric or Gastroesophageal Junction Adenocarcinoma |
The First Affiliated Hospital with Nanjing Medical University |
2026-09-01 | PHASE2 |
| NCT06988852 | RECRUITING | Colorectal Liver Metastasis (CRLM) |
Tongji Hospital |
2023-05-01 | PHASE2 |
| NCT06958328 | RECRUITING | Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma; Stage II Pancreatic Cancer AJCC v8; Stage III Pancreatic Cancer AJCC v8; Stage IV Pancreatic Cancer AJCC v8 |
NRG Oncology |
2025-08-21 | PHASE3 |
| NCT07184788 | NOT_YET_RECRUITING | Aggressive B-Cell Lymphoma |
Navy General Hospital, Beijing |
2025-10-01 | PHASE2 |
| NCT07580339 | NOT_YET_RECRUITING | Rectal Cancer |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2026-10 | PHASE2 |
| NCT07118527 | RECRUITING | Patients With Unresectable Locally Advanced or Metastatic Untreated Gastric or Gastroesophageal Junction Adenocarcinoma |
Suzhou Suncadia Biopharmaceuticals Co., Ltd. |
2025-08-18 | PHASE3 |
| NCT06628310 | ACTIVE_NOT_RECRUITING | Locally Advanced Unresectable or Metastatic Gastric Adenocarcinoma; Gastroesophageal Junction Adenocarcinoma; Esophageal Adenocarcinoma |
AbbVie |
2024-12-13 | PHASE2 |
| NCT07791758 | NOT_YET_RECRUITING | Metastatic Colorectal Carcinoma |
Nanjing Leads Biolabs Co.,Ltd |
2026-09-04 | PHASE1; PHASE2 |
| NCT07599423 | NOT_YET_RECRUITING | Diffuse Large B Cell Lymphoma (DLBCL) |
The First Affiliated Hospital of Soochow University |
2026-07-22 | PHASE2 |
| NCT06990516 | NOT_YET_RECRUITING | Ovarian Cancer |
Tongji Hospital |
2025-06-01 | PHASE1; PHASE2 |
| NCT05719558 | RECRUITING | Advanced Solid Tumors |
Astellas Pharma Global Development, Inc. |
2023-03-13 | PHASE1 |
| NCT05067283 | RECRUITING | Advanced Solid Tumors |
Merck Sharp & Dohme LLC |
2021-12-17 | PHASE1 |
| NCT07686796 | NOT_YET_RECRUITING | Local Advanced Rectal Cancer; PD-1 Inhibitor; PCSK9 Inhibitor; RCT; Radiotherapy; Capecitabine; Oxaliplatin |
Guangdong Provincial People's Hospital |
2027-01-01 | PHASE3 |
| NCT07283367 | RECRUITING | CRC |
Hansoh BioMedical R&D Company |
2025-12-22 | PHASE1; PHASE2 |
| NCT07365306 | RECRUITING | Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified; Recurrent High Grade B-Cell Lymphoma, Not Otherwise Specified; Recurrent Primary Mediastinal Large B-Cell Lymphoma; Recurrent Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma; Refractory Diffuse Large B-Cell Lymphoma, Not Otherwise Specified; Refractory High Grade B-Cell Lymphoma, Not Otherwise Specified; Refractory Primary Mediastinal Large B-Cell Lymphoma; Refractory Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma |
City of Hope Medical Center |
2026-07-27 | PHASE2 |
| NCT07028424 | NOT_YET_RECRUITING | PDAC - Pancreatic Ductal Adenocarcinoma |
GERCOR - Multidisciplinary Oncology Cooperative Group |
2025-07 | PHASE2 |
| NCT07023315 | RECRUITING | Gastric and Gastroesophageal Junction (GEJ) Adenocarcinoma |
Akeso |
2025-08-14 | PHASE3 |
| NCT07621497 | NOT_YET_RECRUITING | Metastatic Colorectal Cancer (CRC) |
Sun Yat-sen University |
2026-06-01 | PHASE2 |
| NCT07492615 | RECRUITING | Gastric Cancer or Gastroesophageal Junction Adenocarcinoma |
Fudan University |
2026-01-29 | PHASE2 |
| NCT07584135 | RECRUITING | Gastric Adenocarcinoma |
NingBo Junyan Hongshi Biosciences Co., Ltd |
2026-05-28 | PHASE3 |
| NCT07774234 | NOT_YET_RECRUITING | Large B-Cell Lymphoma (LBCL); High-grade B-cell Lymphoma |
The First Affiliated Hospital of Soochow University |
2026-08-20 | PHASE2 |
| NCT06792253 | RECRUITING | Relapsed/Refractory Diffuse Large B-Cell Lymphoma |
BeBetter Med Inc |
2025-01-06 | PHASE3 |
| NCT06963502 | NOT_YET_RECRUITING | Advanced Solid Tumors; Colorectal Cancer; Non-Small Cell Lung Cancer |
Jiangsu Hansoh Pharmaceutical Co., Ltd. |
2025-05-30 | PHASE1 |
| NCT07790445 | NOT_YET_RECRUITING | Malignant Biliary Tract Tumors |
Zhai Wenlong |
2026-07-30 | PHASE4 |
| NCT04340141 | ACTIVE_NOT_RECRUITING | Pancreatic Adenosquamous Carcinoma; Resectable Pancreatic Adenocarcinoma; Stage I Pancreatic Cancer AJCC v8; Stage II Pancreatic Cancer AJCC v8; Stage III Pancreatic Cancer AJCC v8 |
Alliance for Clinical Trials in Oncology |
2020-10-13 | PHASE3 |
| NCT05673772 | ACTIVE_NOT_RECRUITING | Rectal Cancer |
Kyungpook National University Hospital |
2020-10-23 | PHASE2 |
| NCT06662786 | RECRUITING | Colorectal Neoplasms |
Janssen Research & Development, LLC |
2024-10-18 | PHASE3 |
| NCT07606599 | RECRUITING | Biliary Tract Cancer |
Sichuan Baili Pharmaceutical Co., Ltd. |
2026-07-07 | PHASE3 |
| NCT07284992 | RECRUITING | Rectal Cancer; Advanced Stage Colorectal Cancer; Radiotherapy |
Shandong Provincial Hospital |
2025-09-12 | PHASE2 |
| NCT05677490 | RECRUITING | Advanced Esophageal Adenocarcinoma; Advanced Gastric Adenocarcinoma; Advanced Gastroesophageal Junction Adenocarcinoma; Clinical Stage III Esophageal Adenocarcinoma AJCC v8; Clinical Stage III Gastric Cancer AJCC v8; Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8; Clinical Stage IV Esophageal Adenocarcinoma AJCC v8; Clinical Stage IV Gastric Cancer AJCC v8; Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8; Metastatic Esophageal Adenocarcinoma; Metastatic Gastric Adenocarcinoma; Metastatic Gastroesophageal Junction Adenocarcinoma; Unresectable Esophageal Adenocarcinoma; Unresectable Gastric Adenocarcinoma; Unresectable Gastroesophageal Junction Adenocarcinoma |
Alliance for Clinical Trials in Oncology |
2023-01-31 | PHASE3 |
| NCT07238283 | RECRUITING | First-line Treatment of Metastatic Pancreatic Cancer |
Jiangsu HengRui Medicine Co., Ltd. |
2025-12-02 | PHASE3 |
| NCT02885753 | RECRUITING | Colorectal Neoplasms |
Federation Francophone de Cancerologie Digestive |
2016-12 | PHASE3 |
| NCT07716449 | NOT_YET_RECRUITING | Gastric or Gastroesophageal Junction Adenocarcinoma |
Qilu Pharmaceutical Co., Ltd. |
2026-08 | PHASE3 |
| NCT07776639 | RECRUITING | Gastroesophageal Junction Adenocarcinoma; Gastric Adenocarcinoma |
Yongxu Jia |
2026-05-10 | PHASE2 |
| NCT07243938 | NOT_YET_RECRUITING | Locally Advanced Rectal Cancer (LARC); Locally Advanced Gastric/Gastroesophageal Junction Adenocarcinoma; Metastatic Colorectal Cancer (mCRC); Neoadjuvant Therapy |
Tao Zhang |
2026-01-15 | PHASE2 |
| NCT06905509 | RECRUITING | Recurrent Diffuse Large B-Cell Lymphoma; Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified; Recurrent High Grade B-Cell Lymphoma With MYC and BCL2 Rearrangements; Recurrent High Grade B-Cell Lymphoma With MYC and BCL6 Rearrangements; Recurrent High Grade B-Cell Lymphoma, Not Otherwise Specified; Recurrent Nodal Marginal Zone Lymphoma; Recurrent Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma; Refractory Diffuse Large B-Cell Lymphoma; Refractory Diffuse Large B-Cell Lymphoma, Not Otherwise Specified; Refractory High Grade B-Cell Lymphoma With MYC and BCL2 Rearrangements; Refractory High Grade B-Cell Lymphoma With MYC and BCL6 Rearrangements; Refractory High Grade B-Cell Lymphoma, Not Otherwise Specified; Refractory Nodal Marginal Zone Lymphoma; Refractory Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma |
University of California, Davis |
2025-07-31 | PHASE2 |
| NCT07381777 | NOT_YET_RECRUITING | Locally Advanced Rectal Cancer (LARC) |
Gruppo Oncologico Italiano di Ricerca Clinica |
2026-01-31 | PHASE2 |
| NCT01935778 | RECRUITING | Gastric Cancer, Adjuvant Chemotherapy, XO |
Asan Medical Center |
2013-10-02 | PHASE3 |
| NCT07290985 | RECRUITING | Gastroesophageal Adenocarcinoma |
American Association for Cancer Research |
2026-07-20 | PHASE2 |
| NCT07464756 | RECRUITING | Gastric Adenocarcinoma |
The First Affiliated Hospital with Nanjing Medical University |
2026-04-03 | PHASE2 |
| NCT05365581 | RECRUITING | Gastric Adenocarcinoma; Gastroesophageal Junction (GEJ) Adenocarcinoma; Pancreatic Adenocarcinoma |
Astellas Pharma Global Development, Inc. |
2022-06-07 | PHASE1 |
| NCT06944496 | NOT_YET_RECRUITING | Gastric Carcinoma |
RemeGen Co., Ltd. |
2025-05-15 | PHASE3 |
| NCT07569068 | RECRUITING | Gastric or Esophagogastric Junction Adenocarcinoma |
Ruijin Hospital |
2026-04-21 | PHASE2 |
| NCT06733038 | RECRUITING | Colorectal Cancer |
Gruppo Oncologico del Nord-Ovest |
2024-11-15 | PHASE3 |
| NCT06381154 | ACTIVE_NOT_RECRUITING | Locally Advanced Pancreatic Adenocarcinoma; Metastatic Pancreatic Adenocarcinoma; Stage II Pancreatic Cancer AJCC v8; Stage III Pancreatic Cancer AJCC v8; Stage IV Pancreatic Cancer AJCC v8; Unresectable Pancreatic Adenocarcinoma |
Mayo Clinic |
2024-12-06 | PHASE2 |
| NCT06888037 | NOT_YET_RECRUITING | Gastric Adenocarcinoma; GEJ Adenocarcinoma; First-line Therapy; Maintenance Therapy; Fruquintinib; PD-1 |
Ruijin Hospital |
2025-03-31 | PHASE2 |
| NCT06109467 | ACTIVE_NOT_RECRUITING | GastroEsophageal Cancer; Gastric Cancer |
H. Lee Moffitt Cancer Center and Research Institute |
2024-01-12 | PHASE2 |
| NCT06508658 | ACTIVE_NOT_RECRUITING | Diffuse Large B-Cell Lymphoma |
Genmab |
2024-08-13 | PHASE3 |
| NCT06888843 | RECRUITING | Colorectal Cancer |
Nizhny Novgorod Regional Clinical Oncology Center |
2025-02-01 | PHASE2 |
| NCT07480850 | ACTIVE_NOT_RECRUITING | Refractory Diffuse Large B-Cell Lymphoma (DLBCL) |
Cancer Institute and Hospital, Chinese Academy of Medical Sciences |
2026-01-01 | PHASE2 |
| NCT06771622 | ACTIVE_NOT_RECRUITING | Solid Cancer |
FBD Biologics Limited |
2025-03-13 | PHASE1; PHASE2 |
| NCT07113275 | RECRUITING | Rectal Cancer; Total Neoadjuvant Therapy; Radiotherapy; Immunotherapy |
Tao Zhang |
2026-05-15 | PHASE3 |
| NCT07705919 | NOT_YET_RECRUITING | Borderline Resectable Pancreatic Ductal Adenocarcinoma |
Ohio State University Comprehensive Cancer Center |
2026-09-01 | PHASE1; PHASE2 |
| NCT07490262 | RECRUITING | Hepatocellular Carcinoma (HCC) |
Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD. |
2026-03-27 | PHASE2; PHASE3 |
| NCT06540261 | ACTIVE_NOT_RECRUITING | Unresectable Colorectal Cancer |
Ono Pharmaceutical Co., Ltd. |
2021-09-23 | PHASE1 |
| NCT07477743 | RECRUITING | Advanced Solid Tumor Cancer |
HC Biopharma Inc. |
2026-03-17 | PHASE1 |
| NCT07503756 | RECRUITING | Metastatic Colorectal Cancer |
Shanghai Junshi Bioscience Co., Ltd. |
2026-04-25 | PHASE2 |
| NCT04150640 | RECRUITING | Esophageal Adenocarcinoma; Gastric Adenocarcinoma |
University of Wisconsin, Madison |
2020-07-13 | PHASE2 |
| NCT07340151 | RECRUITING | Adenocarcinoma of the Pancreas |
The University of Texas Health Science Center at San Antonio |
2026-03-02 | |
| NCT05404230 | RECRUITING | Peripheral Neuropathy; Colorectal Cancer |
Vejle Hospital |
2022-07-15 | |
| NCT06780787 | RECRUITING | Rectal Adenocarcinoma; Stage IIA Rectal Cancer AJCC v8; Stage III Rectal Cancer AJCC v8 |
City of Hope Medical Center |
2025-05-20 | PHASE2 |
| NCT06544655 | ACTIVE_NOT_RECRUITING | Advanced Solid Tumors |
Bristol-Myers Squibb |
2024-10-10 | PHASE1 |
| NCT05062889 | SUSPENDED | Stage II Colon Cancer; Stage III Colon Cancer; HER2-positive Colon Cancer; RAS Wild-type Colon Cancer |
Gruppo Oncologico del Nord-Ovest |
2023-05-17 | PHASE2 |
| NCT07474727 | RECRUITING | Colorectal Cancer |
Multitude Therapeutics Inc. |
2026-04-29 | PHASE2 |
| NCT06766019 | ACTIVE_NOT_RECRUITING | Pancreatic Cancer |
The First Affiliated Hospital with Nanjing Medical University |
2024-10-16 | PHASE2 |
| NCT05891171 | ACTIVE_NOT_RECRUITING | Advanced Cancer; Advanced Malignancies; Bladder Cancer; Cervical Cancer; Esophageal Cancer; Gastric Cancer; Gastroesophageal-junction Cancer (GEJ); Head and Neck Squamous Cell Carcinoma (HNSCC); Non-Small Cell Lung Cancer (NSCLC); Ovarian Cancer; Renal Cell Carcinoma (RCC); Triple Negative Breast Cancer (TNBC) |
Arcus Biosciences, Inc. |
2023-10-13 | PHASE1 |
| NCT07451652 | RECRUITING | Relapsed/Refractory Diffuse Large B Cell Lymphoma |
Hospital Universitario Dr. Jose E. Gonzalez |
2026-03-17 | PHASE2 |
| NCT07353827 | NOT_YET_RECRUITING | Intrahepatic Cholangiocarcinoma (Icc); Hepatic Arterial Infusion Chemotherapy |
Sun Yat-sen University |
2026-02-01 | PHASE2 |
| NCT06790212 | NOT_YET_RECRUITING | Colon Cancer |
Sun Yat-sen University |
2025-04-28 | PHASE2 |
| NCT07030140 | RECRUITING | Cholangiocarcinoma; Hilar Cholangiocarcinoma; Bile Duct Cancer |
Jinbo Yue |
2025-07-01 | PHASE2 |
| NCT03977233 | RECRUITING | Pancreatic Ductal Adenocarcinoma (PDAC); Cancer of Pancreas; Pancreatic Cancer, Adult; Pancreas Adenocarcinoma; Pancreatic Neoplasms; Pancreatic Cancer Non-resectable; Pancreatic Cancer Resectable |
UNC Lineberger Comprehensive Cancer Center |
2019-06-12 | PHASE2 |
| NCT06502080 | NOT_YET_RECRUITING | Biliary Tract Cancer |
Shanghai Zhongshan Hospital |
2024-07 | PHASE2 |
| NCT03505320 | ACTIVE_NOT_RECRUITING | Pharmacokinetics of Zolbetuximab; Gastric Cancer; Gastro-esophageal Junction (GEJ) Cancer; Pharmacokinetics of Oxaliplatin; Pharmacokinetics of Fluorouracil Bolus (5-FU) |
Astellas Pharma Global Development, Inc. |
2018-06-29 | PHASE2 |
| NCT05279300 | SUSPENDED | Advanced Solid Tumor; Advanced Lymphoma |
CStone Pharmaceuticals |
2022-03-28 | PHASE1 |
| NCT06576037 | RECRUITING | Solid Tumor |
M.D. Anderson Cancer Center |
2024-10-31 | PHASE1 |
| NCT04919226 | ACTIVE_NOT_RECRUITING | Neuroendocrine Tumors |
ITM Solucin GmbH |
2021-12-21 | PHASE3 |
| NCT06078709 | RECRUITING | Clinical Stage I Esophageal Adenocarcinoma AJCC v8; Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8; Clinical Stage II Esophageal Adenocarcinoma AJCC v8; Clinical Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8; Clinical Stage III Esophageal Adenocarcinoma AJCC v8; Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 |
Mayo Clinic |
2023-11-20 | PHASE2 |
| NCT07570914 | NOT_YET_RECRUITING | Colorectal Cancer Liver Metastases (CRLM); Colorectal Cancer; Liver Metastasis |
Tianjin Medical University Cancer Institute and Hospital |
2026-05-30 | PHASE2 |
| NCT07462143 | RECRUITING | Colorectal (Colon or Rectal) Cancer |
RemeGen Co., Ltd. |
2026-05-12 | PHASE2; PHASE3 |
| NCT06281925 | SUSPENDED | Colon Cancer; Peripheral Neuropathy |
NYU Langone Health |
2025-03-13 | |
| NCT05794750 | NOT_YET_RECRUITING | Locally Advanced Rectal Cancer |
JIN JING |
2023-04-24 | PHASE2 |
| NCT05802056 | ACTIVE_NOT_RECRUITING | Clinical Stage IV Gastric Cancer AJCC v8; Gastric Adenocarcinoma; Gastroesophageal Junction Adenocarcinoma; Metastatic Gastric Carcinoma; Metastatic Malignant Neoplasm in the Peritoneum |
Mayo Clinic |
2023-11-29 | PHASE1 |
| NCT07081022 | ACTIVE_NOT_RECRUITING | B-cell Non-Hodgkin's Lymphoma |
Shanghai Junshi Bioscience Co., Ltd. |
2025-08-17 | PHASE2 |
| NCT06494514 | RECRUITING | Locally Advanced Pancreatic Cancer |
Du Juan |
2024-04-01 | |
| NCT06383078 | NOT_YET_RECRUITING | Efficacy and Safety |
The First Affiliated Hospital with Nanjing Medical University |
2024-04-20 | PHASE2 |
| NCT06929624 | RECRUITING | Diffuse Large B-cell Lymphoma |
Suzhou Suncadia Biopharmaceuticals Co., Ltd. |
2025-04-24 | PHASE3 |
| NCT07229846 | NOT_YET_RECRUITING | Colorectal Cancer |
Yanqiao Zhang |
2026-02 | PHASE2 |
| NCT07446465 | NOT_YET_RECRUITING | Colorectal Cancer (Locally Advanced or Metastatic); Colorectal Cancer Microsatellite Stable (MSS) |
Ye Xu |
2026-03-01 | PHASE4 |
| NCT04927780 | ACTIVE_NOT_RECRUITING | Pancreatic Cancer; Pancreatic Ductal Adenocarcinoma; Resectable Pancreatic Adenocarcinoma |
Erasmus Medical Center |
2021-09-07 | PHASE3 |
| NCT07025174 | RECRUITING | Bile Duct Carcinoma; Gall Bladder Cancer; Biliary Tract Cancer; Cholangiocarcinoma |
First Affiliated Hospital of Zhejiang University |
2025-06-01 | PHASE2 |
| NCT06808971 | RECRUITING | Gastric Adenocarcinoma; Gastro-esophageal Junction Adenocarcinoma |
Cancer Institute and Hospital, Chinese Academy of Medical Sciences |
2025-02-28 | PHASE2 |
| NCT04460352 | RECRUITING | Esophageal Squamous Cell Carcinoma |
Karolinska University Hospital |
2020-11-27 | PHASE3 |
| NCT03784326 | ACTIVE_NOT_RECRUITING | Clinical Stage II Esophageal Adenocarcinoma AJCC v8; Clinical Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8; Clinical Stage IIA Esophageal Adenocarcinoma AJCC v8; Clinical Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8; Clinical Stage IIB Esophageal Adenocarcinoma AJCC v8; Clinical Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8; Clinical Stage III Esophageal Adenocarcinoma AJCC v8; Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8; Pathologic Stage IB Esophageal Adenocarcinoma AJCC v8; Pathologic Stage IB Gastroesophageal Junction Adenocarcinoma AJCC v8; Pathologic Stage IC Esophageal Adenocarcinoma AJCC v8; Pathologic Stage IC Gastroesophageal Junction Adenocarcinoma AJCC v8; Pathologic Stage II Esophageal Adenocarcinoma AJCC v8; Pathologic Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8; Pathologic Stage IIA Esophageal Adenocarcinoma AJCC v8; Pathologic Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8; Pathologic Stage IIB Esophageal Adenocarcinoma AJCC v8; Pathologic Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8; Pathologic Stage III Esophageal Adenocarcinoma AJCC v8; Pathologic Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8; Pathologic Stage IIIA Esophageal Adenocarcinoma AJCC v8; Pathologic Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8; Pathologic Stage IIIB Esophageal Adenocarcinoma AJCC v8; Pathologic Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8 |
M.D. Anderson Cancer Center |
2019-02-19 | PHASE2 |
| NCT06439550 | NOT_YET_RECRUITING | HER2-positive Gastric Cancer |
The First Affiliated Hospital of Zhengzhou University |
2024-07-15 | PHASE2 |
| NCT05668884 | RECRUITING | Biliary Tract Carcinoma |
Fudan University |
2022-10-18 | PHASE2 |
| NCT03776487 | ACTIVE_NOT_RECRUITING | Clinical Stage 0 Gastric Cancer AJCC v8; Clinical Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8; Clinical Stage I Gastric Cancer AJCC v8; Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8; Clinical Stage IIB Gastric Cancer AJCC v8; Clinical Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8; Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8; Clinical Stage IVA Gastric Cancer AJCC v8; Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8; Gastric Adenocarcinoma; Localized Gastric Carcinoma; Localized Gastroesophageal Junction Adenocarcinoma; Pathologic Stage 0 Gastric Cancer AJCC v8; Pathologic Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8; Pathologic Stage I Gastric Cancer AJCC v8; Pathologic Stage IA Gastric Cancer AJCC v8; Pathologic Stage IA Gastroesophageal Junction Adenocarcinoma AJCC v8; Pathologic Stage IB Gastric Cancer AJCC v8; Pathologic Stage IB Gastroesophageal Junction Adenocarcinoma AJCC v8; Pathologic Stage IC Gastroesophageal Junction Adenocarcinoma AJCC v8; Pathologic Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8; Pathologic Stage IIA Gastric Cancer AJCC v8; Pathologic Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8; Pathologic Stage IIB Gastric Cancer AJCC v8; Pathologic Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8; Pathologic Stage IIIA Gastric Cancer AJCC v8; Pathologic Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8; Pathologic Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8 |
M.D. Anderson Cancer Center |
2019-01-07 | PHASE2 |
| NCT06510010 | RECRUITING | Chemotherapy Effect |
Sixth Affiliated Hospital, Sun Yat-sen University |
2024-12-31 | PHASE2 |
| NCT03773367 | ACTIVE_NOT_RECRUITING | Resectable Gastric and Gastroesophageal Junction Adenocarcinoma |
Lund University Hospital |
2018-12-14 | PHASE2 |
| NCT06648785 | ENROLLING_BY_INVITATION | GI Cancers |
University of Vermont Medical Center |
2024-10-21 | PHASE2 |
| NCT06447662 | ACTIVE_NOT_RECRUITING | Carcinoma, Pancreatic Ductal; Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung |
Pfizer |
2024-06-27 | PHASE1 |
| NCT05564403 | ACTIVE_NOT_RECRUITING | Advanced Biliary Tract Carcinoma; Advanced Gallbladder Carcinoma; Advanced Intrahepatic Cholangiocarcinoma; Recurrent Biliary Tract Carcinoma; Recurrent Gallbladder Carcinoma; Recurrent Intrahepatic Cholangiocarcinoma; Stage III Distal Bile Duct Cancer AJCC v8; Stage III Gallbladder Cancer AJCC v8; Stage III Hilar Cholangiocarcinoma AJCC v8; Stage III Intrahepatic Cholangiocarcinoma AJCC v8; Stage IV Distal Bile Duct Cancer AJCC v8; Stage IV Gallbladder Cancer AJCC v8; Stage IV Hilar Cholangiocarcinoma AJCC v8; Stage IV Intrahepatic Cholangiocarcinoma AJCC v8; Unresectable Biliary Tract Carcinoma; Unresectable Gallbladder Carcinoma; Unresectable Intrahepatic Cholangiocarcinoma |
National Cancer Institute (NCI) |
2024-02-09 | PHASE2 |
| NCT06269978 | ACTIVE_NOT_RECRUITING | Metastatic Colorectal Carcinoma; Metastatic Malignant Neoplasm in the Peritoneum; Stage IV Colorectal Cancer AJCC v8 |
Arjun Mittra |
2024-12-31 | PHASE1 |
| NCT06776770 | RECRUITING | Gastric Cancer |
Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center |
2024-08-03 | PHASE1; PHASE2 |
| NCT04246684 | ACTIVE_NOT_RECRUITING | Rectal Cancer Stage III |
Prof. Dr. med. Claus Rödel |
2020-11-05 | PHASE3 |
| NCT05970627 | NOT_YET_RECRUITING | Adenocarcinoma of the Stomach; Adenocarcinoma of Esophagogastric Junction; Epstein-Barr Virus-Associated Gastric Carcinoma |
Yu jiren |
2023-07-28 | PHASE2 |
| NCT04375605 | COMPLETED | Gastroesophageal Junction Adenocarcinoma |
Universitätsmedizin Mannheim |
2020-06-03 | PHASE3 |
| NCT06884670 | COMPLETED | Rectal Cancer |
The First Affiliated Hospital with Nanjing Medical University |
2024-08-18 | PHASE2 |
| NCT06447636 | ACTIVE_NOT_RECRUITING | Gastric Cancer; Gastro Esophageal Junction Cancer |
Fudan University |
2024-09-30 | PHASE2 |
| NCT06704724 | TERMINATED | Carcinoma, Pancreatic Ductal; Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung |
Pfizer |
2024-12-10 | PHASE1 |
| NCT06507371 | ACTIVE_NOT_RECRUITING | Rectal Cancer |
Sir Run Run Shaw Hospital |
2024-07-29 | PHASE3 |
| NCT06251297 | RECRUITING | Colorectal Cancer |
University Hospital, Toulouse |
2024-04-29 | |
| NCT06405139 | RECRUITING | Colorectal Cancer |
Cancer Institute and Hospital, Chinese Academy of Medical Sciences |
2024-05-01 | PHASE2 |
| NCT04481204 | WITHDRAWN | Borderline Resectable Pancreatic Adenocarcinoma; Locally Advanced Pancreatic Ductal Adenocarcinoma; Resectable Pancreatic Ductal Adenocarcinoma |
M.D. Anderson Cancer Center |
2023-04-18 | PHASE2 |
| NCT06011772 | ACTIVE_NOT_RECRUITING | Colo-rectal Cancer |
Roswell Park Cancer Institute |
2023-12-18 | EARLY_PHASE1 |
| NCT05836584 | ACTIVE_NOT_RECRUITING | Clinical Stage I Gastric Cancer AJCC v8; Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8; Clinical Stage II Gastric Cancer AJCC v8; Clinical Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8; Clinical Stage III Gastric Cancer AJCC v8; Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8; Clinical Stage IVA Gastric Cancer AJCC v8; Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8; Gastric Adenocarcinoma; Gastroesophageal Junction Adenocarcinoma |
National Cancer Institute (NCI) |
2023-12-06 | PHASE2 |
| NCT06225622 | UNKNOWN | Metastatic Colorectal Cancer |
Shanghai Zhongshan Hospital |
2024-03-11 | PHASE1 |
| NCT04819971 | UNKNOWN | Stomach Cancer |
The First Affiliated Hospital of Zhengzhou University |
2021-12-01 | PHASE2 |
| NCT04257461 | UNKNOWN | Small Bowel Adenocarcinoma |
Belgian Group of Digestive Oncology |
2020-02-20 | PHASE3 |
| NCT07117435 | RECRUITING | Colorectal Liver Metastases; First-line Treatment |
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. |
2025-05-13 | PHASE1 |
| NCT04043195 | ACTIVE_NOT_RECRUITING | Advanced NSCLC |
Hatim Husain |
2019-08-14 | PHASE1; PHASE2 |
| NCT04861558 | RECRUITING | Colorectal Cancer; Peritoneal Metastases |
Uppsala University |
2021-05-01 | PHASE3 |
| NCT06164327 | UNKNOWN | Relapsed/Refractory Diffuse Large B-Cell Lymphoma |
BeBetter Med Inc |
2023-12-01 | PHASE1 |
| NCT04649385 | COMPLETED | Advanced Solid Tumor |
BeiGene |
2021-03-04 | PHASE1 |
| NCT03281369 | TERMINATED | Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma or Esophageal Carcinoma |
Hoffmann-La Roche |
2017-10-13 | PHASE1; PHASE2 |
| NCT06086197 | RECRUITING | Diffuse Large B-cell Lymphoma Recurrent; Diffuse Large B Cell Lymphoma Refractory |
Zhejiang Cancer Hospital |
2023-10-01 | PHASE2 |
| NCT06023758 | RECRUITING | HER2-positive Locally Advanced Resectable Gastric Cancer |
Peking University |
2023-09-22 | PHASE2 |
| NCT05325528 | UNKNOWN | Liver Metastases |
Zhejiang University |
2022-04-10 | PHASE2; PHASE3 |
| NCT05007106 | COMPLETED | Uterine Cervical Neoplasms; Endometrial Neoplasms; Squamous Cell Carcinoma of Head and Neck; Gallbladder Neoplasms; Cholangiocarcinoma; Esophageal Neoplasms; Triple Negative Breast Neoplasms; Hepatocellular Carcinoma; Urinary Bladder Neoplasms; Ovarian Neoplasms; Stomach Neoplasms |
Merck Sharp & Dohme LLC |
2021-09-16 | PHASE2 |
| NCT05914389 | RECRUITING | Colon Neoplasm |
Second Affiliated Hospital, Zhejiang University, School of Medicine |
2023-08 | PHASE2 |
| NCT05980481 | ACTIVE_NOT_RECRUITING | Gastric Cancer |
RemeGen Co., Ltd. |
2023-08-04 | PHASE2; PHASE3 |
| NCT05479240 | NOT_YET_RECRUITING | Immunotherapy |
Fujian Cancer Hospital |
2023-09-01 | PHASE2 |
| NCT05859750 | RECRUITING | Pancreatic Cancer |
Akeso |
2023-05-25 | PHASE2 |
| NCT06475417 | UNKNOWN | Gastric Cancer |
Tang-Du Hospital |
2024-05-24 | PHASE2 |
| NCT05177133 | RECRUITING | Gastric Adenocarcinoma; Esophageal Adenocarcinoma |
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) |
2021-11-05 | PHASE2 |
| NCT06225999 | COMPLETED | Metastatic Adenocarcinoma of the Pancreas |
Institut de Recherches Internationales Servier |
2024-04-25 | PHASE2 |
| NCT06210360 | NOT_YET_RECRUITING | Pancreatic Cancer |
Changhai Hospital |
2024-02-01 | PHASE2 |
| NCT02931890 | ACTIVE_NOT_RECRUITING | Gastric Cancer |
The Netherlands Cancer Institute |
2017-12-21 | PHASE2 |
| NCT05171647 | ACTIVE_NOT_RECRUITING | Non-Hodgkin Lymphoma |
Hoffmann-La Roche |
2022-04-25 | PHASE3 |
| NCT04787354 | RECRUITING | Gastric Cancer |
Hallym University Medical Center |
2021-11-01 | PHASE3 |
| NCT04447092 | UNKNOWN | Pancreatic Cancer; Chemotherapy Effect |
Seoul National University Hospital |
2020-07-01 | PHASE2 |
| NCT05291286 | COMPLETED | Neuropathy;Peripheral; Chemotherapy-induced Peripheral Neuropathy |
Bexion Pharmaceuticals, Inc. |
2022-10-17 | EARLY_PHASE1 |
| NCT05546853 | COMPLETED | Pancreatic Ductal Adenocarcinoma |
University Hospital, Grenoble |
2023-03-28 | PHASE1 |
| NCT04891900 | UNKNOWN | Gastric Cancer; Adenocarcinoma of Esophagogastric Junction |
Henan Cancer Hospital |
2021-05-10 | |
| NCT01628211 | UNKNOWN | Colorectal Cancer |
National Cancer Institute, Naples |
2012-04 | PHASE2 |
| NCT05960955 | RECRUITING | Resectable Gastric or Gastroesophageal Junction Adenocarcinoma |
Akeso |
2023-11-13 | PHASE2 |
| NCT04134897 | UNKNOWN | Rectal Neoplasms Malignant; Rectum Carcinoma; Rectal Cancer |
Blokhin's Russian Cancer Research Center |
2019-10-14 | PHASE3 |
| NCT05510856 | COMPLETED | Oncology |
Tanta University |
2022-09-01 | PHASE4 |
| NCT05585814 | ACTIVE_NOT_RECRUITING | Locally Advanced Rectal Cancer |
Shanghai Changzheng Hospital |
2023-05-01 | PHASE2 |
| NCT03478488 | ACTIVE_NOT_RECRUITING | Biliary Tract Neoplasms |
3D Medicines (Sichuan) Co., Ltd. |
2018-04-16 | PHASE3 |
| NCT05964543 | UNKNOWN | Gastroesophageal Junction (GEJ) Adenocarcinoma |
QureBio Ltd. |
2023-06-21 | PHASE1; PHASE2 |
| NCT05048524 | UNKNOWN | Pancreatic Ductal Adenocarcinoma; Pancreas Cancer |
National Health Research Institutes, Taiwan |
2021-09-03 | PHASE2 |
| NCT03722680 | SUSPENDED | Oxaliplatin-induced Peripheral Neuropathy |
UNICANCER |
2020-10-28 | PHASE2 |
| NCT05251727 | TERMINATED | Chemotherapy-induced Peripheral Neuropathy |
Veloxis Pharmaceuticals |
2022-03-24 | PHASE1 |
| NCT04351867 | UNKNOWN | Stomach Neoplasms |
LiNing |
2020-09 | PHASE3 |
| NCT04301557 | UNKNOWN | DMMR Colorectal Cancer; MSI-H Colorectal Cancer; Locally Advanced Colorectal Cancer |
Sun Yat-sen University |
2020-07-31 | PHASE2 |
| NCT06197438 | UNKNOWN | Gastric Cancer |
Fujian Cancer Hospital |
2024-01-01 | PHASE2 |
| NCT06320301 | Recruiting | Biliary Tract Cancer|Gemox Chemotherapy |
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University|Suzhou Suncadia Biopharmaceuticals Co. Ltd. |
2024-04-01 | Phase 2 |
| NCT02953509 | TERMINATED | Non Hodgkin Lymphoma |
Gilead Sciences |
2016-11-21 | PHASE1; PHASE2 |
| NCT03615326 | COMPLETED | Gastric Neoplasms; Gastroesophageal Junction Adenocarcinoma |
Merck Sharp & Dohme LLC |
2018-10-05 | PHASE3 |
| NCT03388190 | COMPLETED | Colorectal Cancer Metastatic |
University Hospital, Akershus |
2018-05-29 | PHASE2 |
| NCT04882241 | COMPLETED | Gastric Cancer; Gastroesophageal Junction Cancer |
Merck Sharp & Dohme LLC |
2020-07-29 | PHASE3 |
| NCT03362177 | COMPLETED | Chemotherapy-induced Thrombocytopenia |
Amgen |
2019-09-30 | PHASE3 |
| NCT05186558 | UNKNOWN | Lymphoma, Large B-Cell, Diffuse; Neoplasms by Histologic Type |
The First Affiliated Hospital with Nanjing Medical University |
2022-05-15 | PHASE2 |
| NCT05608785 | UNKNOWN | Gastric Cancer; Gastroesophageal-junction Cancer |
Henan Cancer Hospital |
2023-01-01 | PHASE1; PHASE2 |
| NCT04047953 | RECRUITING | Gastric Adenocarcinoma |
Peking University Cancer Hospital & Institute |
2019-09-10 | |
| NCT05246982 | UNKNOWN | Gastric Cancer (GC) Gastroesophageal Junction Cancer (GEJ) |
Shanghai Henlius Biotech |
2022-03-23 | PHASE2 |
| NCT04668976 | UNKNOWN | Colorectal Cancer; Cholangiocarcinoma |
Benaroya Research Institute |
2020-11-25 | PHASE2 |
| NCT04933227 | TERMINATED | Stomach Neoplasms; Gastric Cancer; Gastroesophageal Junction Adenocarcinoma |
Hoffmann-La Roche |
2021-08-06 | PHASE2 |
| NCT02399410 | COMPLETED | Colorectal Neoplasms |
University Hospital, Ghent |
2015-11-04 | PHASE2 |
| NCT04034459 | UNKNOWN | Metastatic Colorectal Cancer |
Ludwig-Maximilians - University of Munich |
2016-11-25 | PHASE2 |
| NCT03483038 | ACTIVE_NOT_RECRUITING | Pancreatic Adenocarcinoma |
University of Florida |
2018-12-13 | PHASE2 |
| NCT03153280 | TERMINATED | Colorectal Neoplasms; Stomach Neoplasm; Esophageal Neoplasms |
Cancer Trials Ireland |
2022-01-13 | PHASE1 |
| NCT04117945 | ACTIVE_NOT_RECRUITING | BRAF V600E Negative; KRAS Gene Mutation Negative; Locally Advanced Unresectable Colorectal Adenocarcinoma; Metastatic Colorectal Adenocarcinoma; NRAS Gene Mutation Negative; Stage III Colorectal Cancer AJCC v8; Stage IIIA Colorectal Cancer AJCC v8; Stage IIIB Colorectal Cancer AJCC v8; Stage IIIC Colorectal Cancer AJCC v8; Stage IV Colorectal Cancer AJCC v8; Stage IVA Colorectal Cancer AJCC v8; Stage IVB Colorectal Cancer AJCC v8; Stage IVC Colorectal Cancer AJCC v8 |
Academic and Community Cancer Research United |
2020-03-03 | PHASE2 |
| NCT05594381 | UNKNOWN | Gastric Cancer |
The First Affiliated Hospital with Nanjing Medical University |
2022-10 | PHASE2 |
| NCT05922358 | Not yet recruiting | Gastrointestinal Tumors |
Fujian Cancer Hospital |
2023-09-01 | Phase 2 |
| NCT03676517 | UNKNOWN | Locally Advanced Rectal Cancer |
Yonsei University |
2019-03 | |
| NCT05866653 | UNKNOWN | Oxaliplatin Induced Peripheral Neuropathy in Cancer Patients |
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh |
2023-03-25 | PHASE2 |
| NCT04808791 | COMPLETED | Gastroesophageal Junction Adenocarcinoma; Advanced Gastric Carcinoma |
AHS Cancer Control Alberta |
2021-10-27 | PHASE2 |
| NCT04863430 | WITHDRAWN | Gastric Cancer |
Peking University |
2021-05-11 | PHASE2 |
| NCT05780684 | Recruiting | Colorectal Cancer|Esophagus Cancer|Appendix Cancer|Small Bowel Cancer|Ampullary Cancer |
Dartmouth-Hitchcock Medical Center |
2023-07-14 | Not Applicable |
| NCT04068103 | ACTIVE_NOT_RECRUITING | Colon Adenocarcinoma; Stage IIA Colon Cancer AJCC v8 |
NRG Oncology |
2019-12-16 | PHASE2; PHASE3 |
| NCT04513951 | COMPLETED | Metastatic Colorectal Cancer |
Gruppo Oncologico del Nord-Ovest |
2020-04-01 | PHASE2 |
| NCT03813784 | COMPLETED | Gastric Cancer; GastroEsophageal Cancer |
Jiangsu HengRui Medicine Co., Ltd. |
2019-03-07 | PHASE3 |
| NCT04761614 | COMPLETED | Metastatic Colorectal Carcinoma; Stage IV Colorectal Cancer AJCC v8; Stage IVA Colorectal Cancer AJCC v8; Stage IVB Colorectal Cancer AJCC v8; Stage IVC Colorectal Cancer AJCC v8 |
Ning Jin |
2021-04-02 | PHASE1 |
| NCT04948788 | UNKNOWN | Recurrent and Refractory B-cell Non-Hodgkin's Lymphoma |
Jiangsu HengRui Medicine Co., Ltd. |
2021-10 | PHASE2 |
| NCT05216653 | COMPLETED | MSS Locally Advanced Rectal Adenocarcinoma |
Sir Run Run Shaw Hospital |
2022-04-07 | PHASE2 |
| NCT05056389 | UNKNOWN | Peritoneal Metastases; Colo-rectal Cancer |
Oslo University Hospital |
2021-09-17 | PHASE1 |
| NCT05103020 | UNKNOWN | Metastatic Colorectal Cancer |
Yonsei University |
2021-11-01 | PHASE2 |
| NCT05588297 | UNKNOWN | Colorectal Cancer Liver Metastases |
Shanghai Changzheng Hospital |
2022-10 | PHASE2 |
| NCT04894123 | TERMINATED | Colorectal Adenocarcinoma; Oesogastric |
GERCOR - Multidisciplinary Oncology Cooperative Group |
2022-02-07 | PHASE2 |
| NCT04675983 | TERMINATED | Gastric Adenocarcinoma |
Innovent Biologics (Suzhou) Co. Ltd. |
2021-03-10 | PHASE3 |
| NCT03279289 | COMPLETED | Metastatic Colorectal Cancer |
Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) |
2017-10-25 | PHASE2 |
| NCT05322590 | Recruiting | Metastatic Colorectal Carcinoma|Neuropathy |
Bexion Pharmaceuticals Inc.|ICON plc|CTI Clinical Trial and Consulting Services |
2023-01-09 | Phase 1|Phase 2 |
| NCT05396326 | UNKNOWN | Gastric Cancer |
Shanghai Zhongshan Hospital |
2022-06-01 | PHASE1 |
| NCT03726021 | COMPLETED | Overall Survival |
Qingdao Central Hospital |
2018-01-26 | PHASE2 |
| NCT02919787 | ACTIVE_NOT_RECRUITING | Pancreatic Cancer |
Oslo University Hospital |
2016-09 | PHASE2; PHASE3 |
| NCT03365765 | COMPLETED | Apatinib |
Huashan Hospital |
2018-02-12 | PHASE3 |
| NCT04663763 | UNKNOWN | Locally Advanced Rectal Cancer |
Zhejiang Cancer Hospital |
2020-12-01 | PHASE2 |
| NCT04483076 | RECRUITING | Gastric Cancer; Chemotherapy Effect |
Chinese PLA General Hospital |
2021-01-13 | PHASE3 |
| NCT03750786 | COMPLETED | Colo-rectal Cancer |
Isofol Medical AB |
2018-12-18 | PHASE3 |
| NCT04913376 | COMPLETED | Quality of Life; Chemotherapy-induced Peripheral Neuropathy |
Universitaire Ziekenhuizen KU Leuven |
2021-05-17 | |
| NCT03504397 | ACTIVE_NOT_RECRUITING | Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer; Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer; Metastatic Gastric Adenocarcinoma or Cancer; Metastatic Gastroesophageal Junction (GEJ) Adenocarcinoma |
Astellas Pharma Global Development, Inc. |
2018-06-21 | PHASE3 |
| NCT04354662 | COMPLETED | Gastric Cancer |
Tianjin Medical University Cancer Institute and Hospital |
2020-05-25 | PHASE2 |
| NCT04097444 | UNKNOWN | Metastatic Colorectal Cancer |
Chugai Pharmaceutical |
2019-10-11 | PHASE2 |
| NCT04324476 | UNKNOWN | Advanced Colorectal Cancer |
Jiangsu Cancer Institute & Hospital |
2019-09-01 | PHASE2 |
| NCT04250948 | UNKNOWN | Gastric Cancer; Locally Advanced Solid Tumor |
Sun Yat-sen University |
2019-10-12 | PHASE2 |
| NCT02635971 | UNKNOWN | Carcinoma, Pancreatic |
Fudan University |
2015-12 | PHASE2 |
| NCT03970694 | TERMINATED | Colon Cancer |
Sun Yat-sen University |
2019-05-11 | PHASE3 |
| NCT03125980 | RECRUITING | Locally Advanced Colon Cancer |
Fudan University |
2017-05 | PHASE3 |
| NCT04367025 | UNKNOWN | Gastric Cancer |
Chinese PLA General Hospital |
2020-05 | PHASE2 |
| NCT02833753 | COMPLETED | Colorectal Cancer; Appendix Cancer; Peritoneal Carcinomatosis |
University of Massachusetts, Worcester |
2016-07 | PHASE1 |
| NCT04003792 | UNKNOWN | Liver Metastasis Colon Cancer |
Rabin Medical Center |
2020-01-01 | PHASE2 |
| NCT03788226 | UNKNOWN | Gastric Cancer Stage III |
Fujian Cancer Hospital |
2019-02-01 | PHASE3 |
| NCT03991104 | WITHDRAWN | Esophageal Cancer |
Zhejiang Provincial People's Hospital |
2019-05-01 | PHASE1; PHASE2 |
| NCT03698461 | COMPLETED | Colorectal Neoplasms; Neoplasm Metastasis; Colonic Neoplasms; Rectal Neoplasms |
Asan Medical Center |
2019-05-15 | PHASE2 |
| NCT04282590 | WITHDRAWN | Chemotherapy-induced Peripheral Neuropathy |
Toray Industries, Inc |
2020-04 | PHASE2 |
| NCT02555358 | COMPLETED | Gastric Cancer |
Qun Zhao |
2014-11 | PHASE2 |
| NCT01897454 | TERMINATED | Pancreatic Adenocarcinoma; Stage IIA Pancreatic Cancer; Stage IIB Pancreatic Cancer; Stage III Pancreatic Cancer |
Albert Einstein College of Medicine |
2012-01-27 | PHASE2 |
| NCT02965248 | UNKNOWN | Locally Advanced Colorectal Cancer |
Fudan University |
2016-11 | PHASE3 |
| NCT04313608 | COMPLETED | B-cell Lymphoma |
Hoffmann-La Roche |
2020-06-04 | PHASE1 |
| NCT04595929 | RECRUITING | Peritoneal Carcinomatosis; Gastric Cancer |
St. Petersburg State Pavlov Medical University |
2020-02-10 | |
| NCT03484195 | UNKNOWN | Colonic Neoplasms; Drug Therapy |
China Medical University, China |
2018-04-01 | PHASE2 |
| NCT02741388 | COMPLETED | B-cell Lymphoma |
The Lymphoma Academic Research Organisation |
2016-10 | PHASE1 |
| NCT04430985 | WITHDRAWN | Metastatic Colorectal Cancer |
Dorte Nielsen |
2020-09-30 | PHASE2 |
| NCT02867839 | TERMINATED | Gastric Cancer |
Peking University Cancer Hospital & Institute |
2017-04-24 | PHASE3 |
| NCT02918747 | UNKNOWN | Lymphoma |
Hunan Cancer Hospital |
2016-09 | PHASE2 |
| NCT04751513 | UNKNOWN | Oxaliplatin-induced Peripheral Neuropathy; Chemotherapy |
Chang Gung Memorial Hospital |
2020-08-21 | |
| NCT04797923 | UNKNOWN | Advanced Gastric Cancer; Peritoneal Carcinomatosis |
Gangnam Severance Hospital |
2019-12-01 | PHASE2 |
| NCT03162510 | COMPLETED | Gastric Cancer in Situ; Pancreatic Cancers; Biliary Cancers |
National Health Research Institutes, Taiwan |
2018-06-26 | PHASE1 |
| NCT03382600 | COMPLETED | Gastric Cancer |
Merck Sharp & Dohme LLC |
2018-03-26 | PHASE2 |
| NCT04158349 | TERMINATED | Colorectal Cancer; Appendiceal Cancer; Peritoneal Carcinoma |
University of Utah |
2021-03-22 | PHASE1 |
| NCT04170179 | UNKNOWN | Hepatocellular Carcinoma |
Sun Yat-sen University |
2019-11-19 | PHASE2 |
| NCT04296240 | UNKNOWN | Rectal Cancer |
Peking University Cancer Hospital & Institute |
2019-03-01 | PHASE2 |
| NCT03722498 | WITHDRAWN | Hepatocellular Carcinoma |
Sun Yat-sen University |
2018-06-01 | PHASE2 |
| NCT03488251 | TERMINATED | Non-hodgkin Lymphoma,B Cell; Refractory Diffuse Large B-Cell Lymphoma; Relapsed Diffuse Large B-Cell Lymphoma |
Molecular Templates, Inc. |
2018-08-20 | PHASE2 |
| NCT04202978 | UNKNOWN | Hepatic Metastasis of Colorectal Cancer |
Zhongshan Hospital Xiamen University |
2020-03-01 | PHASE1; PHASE2 |
| NCT03812523 | UNKNOWN | Chemotherapy-Induced Peripheral Neuropathy |
Southeastern Regional Medical Center |
2019-06 | PHASE2 |
| NCT03043729 | COMPLETED | Rectal Cancer; Rectosigmoid Cancer |
AIO-Studien-gGmbH |
2017-03-06 | PHASE2 |
| NCT04337879 | UNKNOWN | Advanced Colorectal Cancer |
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. |
2020-07-20 | PHASE1; PHASE2 |
| NCT03493061 | COMPLETED | Colo-rectal Cancer; Liver Metastases |
Sun Yat-sen University |
2018-02-01 | PHASE2 |
| NCT01761461 | UNKNOWN | Gastric Cancer |
Samsung Medical Center |
2013-02-06 | PHASE3 |
| NCT02767674 | UNKNOWN | Diffuse Large B Cell Lymphoma |
The First Affiliated Hospital with Nanjing Medical University |
2016-05 | PHASE3 |
| NCT03711240 | UNKNOWN | Colorectal Cancer |
National Cheng-Kung University Hospital |
2019-01-08 | PHASE2 |
| NCT02842580 | TERMINATED | Colorectal Neoplasms |
Federation Francophone de Cancerologie Digestive |
2016-09 | PHASE2 |
| NCT03486678 | COMPLETED | Biliary Tract Cancer; Cholangiocarcinoma |
The First Affiliated Hospital with Nanjing Medical University |
2018-02-10 | PHASE2 |
| NCT04340401 | UNKNOWN | Rectal Cancer |
Peking University Cancer Hospital & Institute |
2020-05-25 | PHASE2 |
| NCT03729687 | UNKNOWN | Rectal Cancer |
Uppsala University |
2016-07-04 | PHASE2 |
| NCT02368860 | COMPLETED | Pancreatic Cancer |
National Cancer Centre, Singapore |
2013-09-17 | PHASE1 |
| NCT02921256 | COMPLETED | Rectal Adenocarcinoma; Stage II Rectal Cancer AJCC v7; Stage III Rectal Cancer AJCC v7 |
National Cancer Institute (NCI) |
2017-01-11 | PHASE2 |
| NCT03349827 | TERMINATED | Peritoneal Metastases From Gastric Cancer |
Wuhan University |
2018-01-05 | |
| NCT03464968 | COMPLETED | Biliary Cancer Metastatic |
Seoul National University Bundang Hospital |
2015-07-29 | PHASE2 |
| NCT02641691 | COMPLETED | Cancer of Rectum; Cancer of the Rectum; Neoplasm, Rectum; Rectal Cancer; Rectum Cancer; Rectum Neoplasms; Adenocarcinoma of the Rectum |
Washington University School of Medicine |
2016-05-27 | PHASE2 |
| NCT02114359 | COMPLETED | Gastric Cancer |
Seoul National University Hospital |
2014-02 | PHASE3 |
| NCT01270724 | COMPLETED | CNS Germ Cell Tumor |
Nationwide Children's Hospital |
2010-08 | PHASE2 |
| NCT03300609 | TERMINATED | Colorectal Adenocarcinoma; RAS Wild Type; Stage III Colorectal Cancer AJCC v7; Stage IIIA Colorectal Cancer AJCC v7; Stage IIIB Colorectal Cancer AJCC v7; Stage IIIC Colorectal Cancer AJCC v7; Stage IV Colorectal Cancer AJCC v7; Stage IVA Colorectal Cancer AJCC v7; Stage IVB Colorectal Cancer AJCC v7 |
University of Southern California |
2018-02-27 | PHASE3 |
| NCT05517239 | COMPLETED | Hepatocellular Carcinoma, Unresectable, Advanced |
Yonsei University |
2015-05-01 | PHASE2 |
| NCT01652196 | COMPLETED | Mucinous Adenocarcinoma of the Colon; Mucinous Adenocarcinoma of the Rectum; Signet Ring Adenocarcinoma of the Colon; Signet Ring Adenocarcinoma of the Rectum; Stage IV Colon Cancer; Stage IV Rectal Cancer |
John Hays |
2012-11-14 | PHASE2 |
| NCT02848443 | COMPLETED | Metastatic Colorectal Cancer |
Institut de Recherches Internationales Servier |
2016-05 | PHASE1 |
| NCT02177552 | UNKNOWN | Esophageal Neoplasms; Stomach Neoplasms |
Rigshospitalet, Denmark |
2014-06 | PHASE2 |
| NCT01913639 | COMPLETED | Esophageal Cancer; Gastric Cancer |
Memorial Sloan Kettering Cancer Center |
2013-07 | PHASE2 |
| NCT02338518 | UNKNOWN | Stomach Neoplasms; Gastric Cancer |
Jinling Hospital, China |
2015-01-04 | PHASE3 |
| NCT01858649 | COMPLETED | Metastatic Colorectal Cancer |
Cliniques universitaires Saint-Luc- Université Catholique de Louvain |
2013-05 | PHASE2 |
| NCT03469557 | COMPLETED | Esophageal Squamous Cell Carcinoma, Gastric Carcinoma, Gastroesophageal Junction Carcinoma |
BeiGene |
2017-07-18 | PHASE2 |
| NCT03294252 | TERMINATED | Digestive Cancer |
Institut Cancerologie de l'Ouest |
2017-05-24 | PHASE1; PHASE2 |
| NCT03197584 | WITHDRAWN | Ovarian Cancer |
ImmunityBio, Inc. |
2017-12 | PHASE1; PHASE2 |
| NCT02322593 | COMPLETED | Gastric Cancer |
Taiho Pharmaceutical Co., Ltd. |
2014-12 | PHASE3 |
| NCT03085914 | COMPLETED | Solid Tumor |
Incyte Corporation |
2017-05-02 | PHASE1; PHASE2 |
| NCT03169777 | WITHDRAWN | Colorectal Cancer |
ImmunityBio, Inc. |
2018-08 | PHASE1; PHASE2 |
| NCT03244774 | UNKNOWN | Gastric Adenocarcinoma |
Fujian Cancer Hospital |
2018-01-01 | PHASE1 |
| NCT03061058 | UNKNOWN | Stomach Neoplasms; Chemotherapy Effect; Chemotherapeutic Toxicity |
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School |
2013-04-01 | PHASE3 |
| NCT02688023 | UNKNOWN | Colorectal Cancer |
Chinese Academy of Medical Sciences |
2014-03 | PHASE2 |
| NCT01992705 | COMPLETED | Resectable Pancreatic Cancer |
University of Maryland, Baltimore |
2014-03 | EARLY_PHASE1 |
| NCT02716766 | COMPLETED | Carcinoma, Hepatocellular; Secondary |
The University of Hong Kong |
2016-03 | PHASE2 |
| NCT02504229 | UNKNOWN | Gastric Cancer |
Beijing Biohealthcare Biotechnology Co.,Ltd |
2014-11 | PHASE2 |
| NCT02855788 | UNKNOWN | Metastatic Gastric Cancer; Locally Advanced Gastric Cancer |
Huashan Hospital |
2015-05 | PHASE2 |
| NCT02970916 | COMPLETED | Metastatic Colorectal Cancer |
Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) |
2016-11 | PHASE2 |
| NCT01516944 | COMPLETED | Gastric Cancer |
Hebei Medical University |
2012-02 | PHASE2; PHASE3 |
| NCT01652976 | COMPLETED | Pancreatic Cancer Metastatic |
University of Florida |
2012-07 | PHASE2 |
| NCT01650428 | COMPLETED | Rectal Cancer |
University College, London |
2013-04 | PHASE2 |
| NCT01503372 | COMPLETED | Advanced Gastric Cancer |
Charite University, Berlin, Germany |
2011-11 | PHASE2 |
| NCT03307941 | WITHDRAWN | Adenocarcinoma of the Esophagus; Adenocarcinoma of the Gastroesophageal Junction; Squamous Cell Carcinoma of the Esophagus |
Jules Bordet Institute |
2017-07-20 | PHASE1; PHASE2 |
| NCT02745561 | UNKNOWN | Esophageal Cancer; Endostatin |
Hangzhou Cancer Hospital |
2016-01 | PHASE2 |
| NCT02604615 | UNKNOWN | Stage III Esophageal Squamous Cell Carcinoma; Esophageal Neoplasms |
The First Affiliated Hospital of Henan University of Science and Technology |
2014-10 | PHASE3 |
| NCT02767375 | UNKNOWN | Hepatocellular Carcinoma |
Peking University Cancer Hospital & Institute |
2015-02 | PHASE2; PHASE3 |
| NCT02539225 | COMPLETED | Metastatic Gastric Adenocarcinoma; Gastroesophageal Junction Adenocarcinoma |
Eli Lilly and Company |
2015-10-05 | PHASE2 |
| NCT02558868 | COMPLETED | Pancreatic Neoplasms |
Zhejiang University |
2015-09-01 | PHASE2 |
| NCT02251977 | COMPLETED | Colorectal Cancer; Chemotherapy-induced Neutropenia |
Yuhong Li |
2014-09 | PHASE3 |
| NCT02860429 | UNKNOWN | Gastrointestinal Neoplasms |
Xiaonan Cui |
2016-09 | PHASE4 |
| NCT01952951 | UNKNOWN | Rectal Neoplasms; Adenocarcinoma |
National Cancer Center, Korea |
2014-06 | PHASE2 |
| NCT02119026 | COMPLETED | Metastatic Colorectal Cancer |
Prof. Dr. Werner Scheithauer |
2011-02 | PHASE2 |
| NCT02129322 | WITHDRAWN | Hepatocellular Carcinoma |
Zhejiang University |
2015-07 | PHASE2 |
| NCT02987699 | UNKNOWN | HepatoCellular Carcinoma |
Sun Yat-sen University |
2016-11 | PHASE2 |
| NCT02337946 | COMPLETED | Colorectal Carcinoma |
Takeda |
2014-10-16 | PHASE2 |
| NCT00501410 | COMPLETED | Colorectal Cancer |
M.D. Anderson Cancer Center |
2007-04-23 | PHASE1 |
| NCT01876927 | COMPLETED | Gastric Cancer; Locally Advanced Malignant Neoplasm |
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS |
2010-09 | PHASE2 |
| NCT02273713 | COMPLETED | Esophageal Cancer; Toxicity |
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) |
2014-10 | PHASE1; PHASE2 |
| NCT00647530 | UNKNOWN | Colorectal Cancer |
University of Birmingham |
2008-05-15 | PHASE2; PHASE3 |
| NCT02557490 | UNKNOWN | Colon Cancer Liver Metastasis |
Zhu Xu |
2015-01 | PHASE4 |
| NCT01747551 | COMPLETED | Esophageal Cancer; Gastric Cancer |
Dana-Farber Cancer Institute |
2013-01 | PHASE2 |
| NCT01364376 | COMPLETED | Stomach Neoplasms |
Zhejiang University |
2011-06 | |
| NCT01231399 | COMPLETED | Adenocarcinoma of the Esophagus; Adenocarcinoma of the Gastroesophageal Junction; Diffuse Adenocarcinoma of the Stomach; Intestinal Adenocarcinoma of the Stomach; Mixed Adenocarcinoma of the Stomach; Recurrent Esophageal Cancer; Recurrent Gastric Cancer; Stage IV Esophageal Cancer; Stage IV Gastric Cancer |
City of Hope Medical Center |
2012-02 | PHASE1; PHASE2 |
| NCT02423278 | UNKNOWN | Gastric Cancer; Surgery; Effects of Chemotherapy |
First Affiliated Hospital, Sun Yat-Sen University |
2010-01 | PHASE2; PHASE3 |
| NCT01362361 | COMPLETED | Colorectal Cancer |
Martin-Luther-Universität Halle-Wittenberg |
2011-06 | PHASE2 |
| NCT02527785 | COMPLETED | Stomach Neoplasm |
Hallym University Medical Center |
2015-02 | PHASE2 |
| NCT01786538 | WITHDRAWN | Metastatic Colorectal Cancer |
Asan Medical Center |
2013-06 | PHASE3 |
| NCT01422993 | COMPLETED | Neuropathy; Gastrointestinal Cancer |
H. Lee Moffitt Cancer Center and Research Institute |
2011-07 | |
| NCT01765582 | TERMINATED | Colorectal Neoplasms |
Hoffmann-La Roche |
2013-01-23 | PHASE2 |
| NCT01206049 | COMPLETED | Cholangiocarcinoma |
Vejle Hospital |
2010-09 | PHASE2 |
| NCT00525785 | COMPLETED | Stomach Cancer; Gastric Cancer |
M.D. Anderson Cancer Center |
2004-01 | PHASE2 |
| NCT01263171 | COMPLETED | Colorectal Cancer |
Cardiff University |
2012-04 | PHASE2 |
| NCT02426450 | UNKNOWN | Hepatocellular Carcinoma |
Sun Yat-sen University |
2015-04 | PHASE2 |
| NCT01580410 | COMPLETED | Carcinoma of the Appendix; Primary Peritoneal Cavity Cancer |
Wake Forest University Health Sciences |
2009-05 | PHASE2 |
| NCT00997685 | UNKNOWN | Potentially Resectable Liver Metastasis From CRC; Colorectal Cancer |
Guangdong Provincial People's Hospital |
2009-11 | PHASE2 |
| NCT01596634 | COMPLETED | Colorectal Cancer; Dysgeusia; Oral Complications of Chemotherapy |
Wake Forest University Health Sciences |
2013-01 | |
| NCT01936974 | TERMINATED | Ovarian Carcinoma; Fallopian Tube Carcinoma; Peritoneal Carcinoma |
Western Regional Medical Center |
2013-09 | PHASE2 |
| NCT01332604 | COMPLETED | Solid Cancers |
Genentech, Inc. |
2011-07 | PHASE1 |
| NCT02105350 | WITHDRAWN | Biliary Tract Carcinoma; Gallbladder Carcinoma |
University Health Network, Toronto |
2015-06 | PHASE1 |
| NCT00526110 | COMPLETED | Gastrointestinal Diseases |
M.D. Anderson Cancer Center |
2004-08 | PHASE1; PHASE2 |
| NCT02169908 | COMPLETED | Digestive Cancer; Gynecological Cancer |
Fondation Hôpital Saint-Joseph |
2014-05 | |
| NCT01487915 | UNKNOWN | Advanced Urothelial Carcinoma |
Asan Medical Center |
2010-10 | PHASE2 |
| NCT01670721 | COMPLETED | Colorectal Cancer Metastatic |
Sanofi |
2012-08 | PHASE3 |
| NCT01843829 | UNKNOWN | Oesophageal Cancer |
Lisette Nixon |
2013-10 | PHASE2 |
| NCT01962376 | UNKNOWN | Gastric Cancer; Liver Metastasis |
Hebei Medical University |
2013-02 | PHASE4 |
| NCT02879227 | COMPLETED | Esophagus Cancer |
Centre Hospitalier Universitaire de Besancon |
2010-01 | PHASE2 |
| NCT00952003 | COMPLETED | Gastric Cancer; Unresectable |
Arbeitsgemeinschaft medikamentoese Tumortherapie |
2009-07 | PHASE2 |
| NCT01450163 | COMPLETED | Pain; Neuropathic Pain; Polyneuropathy |
University of Sao Paulo |
2011-08 | PHASE3 |
| NCT01583361 | UNKNOWN | Gastric Adenocarcinoma |
Lin Chen |
2012-03 | PHASE3 |
| NCT01542294 | UNKNOWN | Gastric Cancer |
Chinese Academy of Medical Sciences |
2011-06 | PHASE1; PHASE2 |
| NCT01472029 | COMPLETED | Adenocarcinoma of the Gastroesophageal Junction; Adenocarcinoma of the Stomach |
AIO-Studien-gGmbH |
2011-12 | PHASE2 |
| NCT00957905 | COMPLETED | Recurrent Extragonadal Seminoma; Recurrent Malignant Extragonadal Germ Cell Tumor; Recurrent Malignant Extragonadal Non-Seminomatous Germ Cell Tumor; Recurrent Malignant Testicular Germ Cell Tumor; Recurrent Ovarian Germ Cell Tumor; Stage III Testicular Cancer; Stage IV Extragonadal Non-Seminomatous Germ Cell Tumor; Stage IV Extragonadal Seminoma; Stage IV Ovarian Germ Cell Tumor |
National Cancer Institute (NCI) |
2009-06 | PHASE2 |
| NCT01183780 | COMPLETED | Colorectal Cancer |
Eli Lilly and Company |
2010-12-02 | PHASE3 |
| NCT02060669 | TERMINATED | Metastatic Colorectal Cancer |
Samsung Medical Center |
2010-06-20 | PHASE3 |
| NCT01229111 | TERMINATED | Adult Primary Cholangiocellular Carcinoma; Advanced Adult Primary Liver Cancer; Cholangiocarcinoma of the Extrahepatic Bile Duct; Cholangiocarcinoma of the Gallbladder; Localized Unresectable Adult Primary Liver Cancer; Periampullary Adenocarcinoma; Recurrent Adult Primary Liver Cancer; Recurrent Extrahepatic Bile Duct Cancer; Recurrent Gallbladder Cancer; Unresectable Extrahepatic Bile Duct Cancer; Unresectable Gallbladder Cancer |
National Cancer Institute (NCI) |
2010-10 | PHASE2 |
| NCT01399684 | COMPLETED | Metastatic Colorectal Cancer |
Genentech, Inc. |
2011-11 | PHASE2 |
| NCT01505413 | COMPLETED | Pancreatic Cancer |
Soonchunhyang University Hospital |
2011-01 | PHASE2 |
| NCT00114231 | COMPLETED | Colorectal Cancer |
Alliance for Clinical Trials in Oncology |
2006-05 | PHASE2 |
| NCT01963702 | UNKNOWN | Gastric Cancer |
Fudan University |
2012-08 | PHASE2 |
| NCT01234051 | UNKNOWN | Biliary Tract Cancer |
Korean South West Oncology Group |
2010-11 | PHASE2 |
| NCT02048540 | COMPLETED | Locally Advanced Gastric Carcinoma |
Chinese PLA General Hospital |
2009-02 | PHASE1; PHASE2 |
| NCT02808091 | TERMINATED | Extranodal NK-T-CELL LYMPHOMA |
National Cancer Centre, Singapore |
2011-03 | PHASE2 |
| NCT00527930 | COMPLETED | Breast Neoplasms |
Seoul National University Hospital |
2007-09 | PHASE2 |
| NCT01972503 | UNKNOWN | Colorectal Neoplasms; Neoplasm Metastasis; Liver Neoplasms |
Xu jianmin |
2008-06 | PHASE4 |
| NCT01063192 | UNKNOWN | Locally Advanced Pancreatic Cancer |
National Health Research Institutes, Taiwan |
2009-11 | PHASE2 |
| NCT01138904 | COMPLETED | Gastric Cancer |
Dong-A University Hospital |
2009-09 | PHASE2 |
| NCT00321685 | COMPLETED | Rectal Adenocarcinoma; Stage II Rectal Cancer AJCC v7; Stage III Rectal Cancer AJCC v7 |
National Cancer Institute (NCI) |
2006-07-25 | PHASE2 |
| NCT01528826 | UNKNOWN | Breast Cancer |
Fudan University |
2011-12 | PHASE2 |
| NCT00803647 | COMPLETED | Metastatic Colorectal Cancer |
NSABP Foundation Inc |
2010-01 | PHASE2 |
| NCT01558453 | UNKNOWN | Relapsed Solid Tumor; Refractory Solid Tumor |
Sidnei Epelman |
2011-03 | PHASE2 |
| NCT00610948 | COMPLETED | Unspecified Adult Solid Tumor, Protocol Specific |
UNC Lineberger Comprehensive Cancer Center |
2008-03 | PHASE1 |
| NCT00646607 | COMPLETED | Colon Cancer |
Gruppo Italiano per lo studio dei Carcinomi dell'Apparato Digerente |
2007-06 | PHASE3 |
| NCT00183898 | COMPLETED | Gastric Cancer; Esophageal Cancer |
University of Southern California |
2004-12-28 | PHASE2 |
| NCT01243775 | COMPLETED | Non-Small Cell Lung Cancer |
Chonnam National University Hospital |
2010-11 | PHASE2 |
| NCT02071043 | COMPLETED | Advanced Gastric Cancer |
Shanghai Zhongshan Hospital |
2008-11 | PHASE2 |
| NCT01090505 | UNKNOWN | Gastric Cancer |
Chinese PLA General Hospital |
2009-11 | PHASE2 |
| NCT00849550 | COMPLETED | Unspecified Adult Solid Tumor, Protocol Specific; Cancer |
Herbert Hurwitz |
2009-07 | PHASE1 |
| NCT00169195 | COMPLETED | Diffuse Large Cell Lymphoma |
Lymphoma Study Association |
2003-04 | PHASE2 |
| NCT01106066 | TERMINATED | Phase I: To Determine the Maximum Tolerated Dose (MTD); Phase II: To Assess the Pathologic CR Rate and Feasibility Following Neoadjuvant Chemoradiation Therapy With S1/Oxaliplatin |
Samsung Medical Center |
2009-03 | PHASE1; PHASE2 |
| NCT02560974 | COMPLETED | Gastric Cancer |
Hoffmann-La Roche |
2006-06 | PHASE3 |
| NCT00398320 | COMPLETED | Neuroendocrine Tumors |
Pamela L. Kunz |
2006-11 | PHASE2 |
| NCT01157039 | WITHDRAWN | Colorectal Carcinoma; Neoplasms, Colorectal; Colorectal Cancer; Colorectal Tumors; Metastasis |
AHS Cancer Control Alberta |
2011-10 | PHASE2 |
| NCT00444678 | COMPLETED | Colorectal Cancer; Neoplasm Metastasis |
NYU Langone Health |
2004-06-01 | PHASE2 |
| NCT00964457 | UNKNOWN | Rectum Cancer |
Copenhagen University Hospital at Herlev |
2009-08 | PHASE2 |
| NCT00988897 | WITHDRAWN | Colorectal Neoplasms |
Sanofi |
2009-10 | PHASE2 |
| NCT00816543 | COMPLETED | Gastric Cancer |
Sanofi |
2008-12 | PHASE2 |
| NCT00677144 | COMPLETED | Colorectal Neoplasm |
Hallym University Medical Center |
2008-04 | PHASE2 |
| NCT01467921 | UNKNOWN | Curatively-resected, Node-positive Esophageal Squamous Cell Carcinoma |
Samsung Medical Center |
2010-12 | PHASE2 |
| NCT00585078 | COMPLETED | Pancreatic Cancer |
Beth Israel Deaconess Medical Center |
2004-05 | PHASE2 |
| NCT00700570 | COMPLETED | Colorectal Cancer |
Hoffmann-La Roche |
2008-08 | PHASE2 |
| NCT00551759 | TERMINATED | Esophageal Cancer |
Eastern Cooperative Oncology Group |
2008-10-02 | PHASE2 |
| NCT00861094 | COMPLETED | Esophageal Cancer |
UNICANCER |
2008-03 | PHASE2; PHASE3 |
| NCT00138177 | COMPLETED | Recurrent Colon Cancer; Recurrent Rectal Cancer; Stage III Colon Cancer; Stage III Rectal Cancer; Stage IV Colon Cancer; Stage IV Rectal Cancer; Unspecified Adult Solid Tumor, Protocol Specific |
National Cancer Institute (NCI) |
2005-07 | PHASE1 |
| NCT00296816 | COMPLETED | Ovarian Cancer |
Sanofi |
2006-03 | PHASE2 |
| NCT01481545 | COMPLETED | Rectal Cancer |
National Cancer Institute, Naples |
2006-12 | PHASE2 |
| NCT00954005 | TERMINATED | Indolent Lymphoma |
German Low Grade Lymphoma Study Group |
2003-01 | PHASE1; PHASE2 |
| NCT00660582 | COMPLETED | Metastatic Colorectal Cancer |
Per Pfeiffer |
2008-04 | PHASE2 |
| NCT01160419 | UNKNOWN | Gastric Cancer |
Ludwig-Maximilians - University of Munich |
2009-12 | PHASE2 |
| NCT00862784 | COMPLETED | Colorectal Carcinoma |
Eli Lilly and Company |
2009-04 | PHASE2 |
| NCT00514020 | COMPLETED | Gastric Cancer |
Vanderbilt-Ingram Cancer Center |
2007-08 | PHASE2 |
| NCT00941967 | COMPLETED | Liver Cancer |
Institut du Cancer de Montpellier - Val d'Aurelle |
2008-12 | PHASE2 |
| NCT01048320 | COMPLETED | Advanced Pancreatic Cancer |
Royal Marsden NHS Foundation Trust |
2006-07 | PHASE1 |
| NCT00689624 | COMPLETED | Metastatic Colorectal Cancer |
University Hospital of Crete |
2007-07 | PHASE2 |
| NCT01067053 | UNKNOWN | Metastatic Colorectal Cancer |
Grupo Espanol Multidisciplinario del Cancer Digestivo |
2009-11 | PHASE2 |
| NCT00436241 | COMPLETED | Gastric Cancer |
Hoffmann-La Roche |
2007-03 | PHASE2 |
| NCT00660725 | COMPLETED | Advanced Incurable Solid Malignancy |
Leonard Appleman |
2009-02 | PHASE1 |
| NCT00839111 | UNKNOWN | Colorectal Neoplasms |
Fudan University |
2008-11 | PHASE2 |
| NCT00480987 | TERMINATED | Myelodysplastic Syndromes; Acute Myeloid Leukemia; Leukemia |
M.D. Anderson Cancer Center |
2007-07 | PHASE1; PHASE2 |
| NCT00525005 | COMPLETED | Stomach Neoplasms |
Hallym University Medical Center |
2007-08 | PHASE2 |
| NCT00112918 | COMPLETED | Colorectal Cancer |
Hoffmann-La Roche |
2004-12 | PHASE3 |
| NCT00399035 | COMPLETED | Metastatic Colorectal Cancer |
AstraZeneca |
2006-11 | PHASE3 |
| NCT00761241 | COMPLETED | Pancreatic Cancer |
Benaroya Research Institute |
2008-09 | PHASE2 |
| NCT00727922 | COMPLETED | Neurotoxic Disorders; Cancer |
Assistance Publique - Hôpitaux de Paris |
2008-06 | PHASE2 |
| NCT00507585 | COMPLETED | Liver Cancer; Advanced Solid Tumors |
M.D. Anderson Cancer Center |
2006-06 | PHASE1 |
| NCT00448682 | TERMINATED | Gastric Cancer |
University of Miami |
2005-06 | PHASE2 |
| NCT00436280 | COMPLETED | Lymphoma, Large Cell, Diffuse |
Eli Lilly and Company |
2007-02 | PHASE2 |
| NCT00831181 | COMPLETED | Colorectal Cancer |
Beth Israel Medical Center |
2004-07 | PHASE2 |
| NCT00266279 | COMPLETED | Head or Neck Cancer |
University of Louisville |
2005-04 | PHASE2 |
| NCT00452881 | UNKNOWN | Lung Cancer |
National Cancer Center, Korea |
2006-05 | PHASE2 |
| NCT00296062 | TERMINATED | Colorectal Cancer; Unspecified Adult Solid Tumor, Protocol Specific |
Case Comprehensive Cancer Center |
2006-03 | PHASE1 |
| NCT00674206 | TERMINATED | Breast Cancer |
Emory University |
2008-10 | PHASE2 |
| NCT00884767 | UNKNOWN | Chemotherapeutic Agent Toxicity; Colorectal Cancer; Neurotoxicity |
Institut Cancerologie de l'Ouest |
2007-09 | PHASE2 |
| NCT00631410 | COMPLETED | Colorectal Neoplasms |
Pfizer |
2008-01 | PHASE1 |
| NCT00602329 | TERMINATED | Colorectal Cancer |
Abramson Cancer Center at Penn Medicine |
2006-02 | PHASE2 |
| NCT00483080 | COMPLETED | Colorectal Cancer (CRC) |
AGC Biologics S.p.A. |
2006-12 | PHASE2 |
| NCT00408551 | UNKNOWN | Colorectal Cancer; Metastatic Cancer |
Goshen Health System |
2005-11 | PHASE2 |
| NCT00568529 | SUSPENDED | Gastric Cancer |
Fudan University |
2007-10 | PHASE2 |
| NCT00711412 | COMPLETED | Esophageal Cancer |
Northwestern University |
2006-05-31 | PHASE2 |
| NCT00338988 | COMPLETED | Cancer of the Gallbladder; Cancer of the Biliary Tract |
M.D. Anderson Cancer Center |
2003-08 | PHASE2 |
| NCT00182715 | UNKNOWN | Colorectal Cancer |
Velindre NHS Trust |
2005-03 | PHASE3 |
| NCT00601172 | COMPLETED | Nausea and Vomiting, Chemotherapy-Induced |
GlaxoSmithKline |
2008-03-10 | PHASE3 |
| NCT00080990 | COMPLETED | Unspecified Adult Solid Tumor, Protocol Specific |
National Cancer Institute (NCI) |
2004-02 | PHASE1 |
| NCT00352755 | TERMINATED | Peritoneal Neoplasms |
Washington University School of Medicine |
2006-05 | PHASE2 |
| NCT00096278 | COMPLETED | Colon Adenocarcinoma; Stage IIA Colon Cancer AJCC v7; Stage IIB Colon Cancer AJCC v7; Stage IIC Colon Cancer AJCC v7; Stage IIIA Colon Cancer AJCC v7; Stage IIIB Colon Cancer AJCC v7; Stage IIIC Colon Cancer AJCC v7 |
National Cancer Institute (NCI) |
2004-09-15 | PHASE3 |
| NCT00859469 | COMPLETED | Mesothelioma |
Columbia University |
2004-04 | PHASE2 |
| NCT00361231 | COMPLETED | Biliary Tract Cancer; Gallbladder Adenocarcinoma |
Massachusetts General Hospital |
2006-05 | PHASE2 |
| NCT00744640 | COMPLETED | Locally Advanced Pancreatic Cancer; Metastatic Pancreatic Cancer |
University Hospital, Basel, Switzerland |
2005-10 | PHASE1; PHASE2 |
| NCT00290615 | COMPLETED | Colorectal Cancer |
Herbert Hurwitz |
2006-01 | PHASE2 |
| NCT00711243 | COMPLETED | Gastric Cancer; Unspecified Adult Solid Tumor, Protocol Specific |
Northwestern University |
2005-04-20 | PHASE1; PHASE2 |
| NCT00536809 | COMPLETED | Neoplasms, Colorectal |
GlaxoSmithKline |
2007-09-26 | PHASE1 |
| NCT00227747 | COMPLETED | Colorectal Cancer |
UNICANCER |
2005-11-08 | PHASE3 |
| NCT00297596 | COMPLETED | Breast Cancer |
SCRI Development Innovations, LLC |
2006-02 | PHASE2 |
| NCT00084617 | COMPLETED | Adenocarcinoma of the Gastroesophageal Junction; Diffuse Adenocarcinoma of the Stomach; Intestinal Adenocarcinoma of the Stomach; Mixed Adenocarcinoma of the Stomach; Recurrent Gastric Cancer; Stage IIIA Gastric Cancer; Stage IIIB Gastric Cancer; Stage IIIC Gastric Cancer; Stage IV Gastric Cancer |
National Cancer Institute (NCI) |
2004-03 | PHASE2 |
| NCT00259402 | COMPLETED | Esophageal Neoplasms |
Sanofi |
2000-02 | PHASE2 |
| NCT01216345 | COMPLETED | Unresectable; Locally Advanced; Metastatic |
Association of Research on the Biology of Liver Tumors |
2006-10 | PHASE2 |
| NCT00345761 | COMPLETED | Colorectal Cancer |
Chugai Pharmaceutical |
2006-02 | PHASE1; PHASE2 |
| NCT00345696 | COMPLETED | Metastatic Colorectal Cancer |
Unidad Integral de Investigación en Oncología S.L. |
2006-06 | PHASE2 |
| NCT00398398 | COMPLETED | Gastric Cancer |
Asan Medical Center |
2006-11 | PHASE2 |
| NCT00447122 | TERMINATED | Metastatic Pancreatic Cancer |
Brown University |
2007-03 | PHASE1 |
| NCT00531245 | COMPLETED | Colorectal Neoplasms |
Samsung Medical Center |
2006-08 | PHASE1; PHASE2 |
| NCT00193219 | COMPLETED | Colon Cancer |
SCRI Development Innovations, LLC |
2005-07 | PHASE2 |
| NCT00253370 | COMPLETED | Adenocarcinoma of the Gastroesophageal Junction; Metastatic Gastric Cancer; Advanced Unresectable Gastric Cancer |
National Cancer Institute (NCI) |
2005-10 | PHASE2 |
| NCT00084643 | COMPLETED | Recurrent Colon Cancer; Recurrent Rectal Cancer; Stage IIIC Colon Cancer; Stage IIIC Rectal Cancer; Stage IVA Colon Cancer; Stage IVA Rectal Cancer; Stage IVB Colon Cancer; Stage IVB Rectal Cancer; Unspecified Adult Solid Tumor, Protocol Specific |
National Cancer Institute (NCI) |
2004-05 | PHASE1 |
| NCT00416494 | COMPLETED | Colorectal Cancer |
Herbert Hurwitz, MD |
2003-09 | PHASE2 |
| NCT00305786 | COMPLETED | Lung Cancer |
University of Miami |
2005-08 | PHASE2 |
| NCT02582970 | COMPLETED | Colorectal Cancer |
Hoffmann-La Roche |
2005-05 | PHASE4 |
| NCT00056030 | COMPLETED | Colorectal Cancer; Metastatic Cancer |
Alliance for Clinical Trials in Oncology |
2004-12 | PHASE2 |
| NCT01538641 | COMPLETED | Refractory Aggressive Non-Hodgkin's Lymphoma; Relapsing Aggressive Non-Hodgkin's Lymphoma |
Auxilio Mutuo Cancer Center |
2003-10 | PHASE2 |
| NCT00217282 | COMPLETED | Non-Small Cell Lung Cancer |
Mt. Sinai Medical Center, Miami |
2004-06 | PHASE2 |
| NCT00216021 | COMPLETED | Metastatic Breast Cancer |
Hoosier Cancer Research Network |
2004-03 | PHASE2 |
| NCT00115765 | COMPLETED | Colorectal Cancer |
Amgen |
2005-06-01 | PHASE3 |
| NCT00087802 | COMPLETED | Carcinoma, Non-Small-Cell Lung |
Sanofi |
2004-03 | PHASE3 |
| NCT00356941 | TERMINATED | Lung Cancer |
Masonic Cancer Center, University of Minnesota |
2006-04 | PHASE1 |
| NCT00470405 | COMPLETED | Lymphoma; Solid Tumor |
Vanderbilt-Ingram Cancer Center |
2004-05 | PHASE1 |
| NCT00118105 | WITHDRAWN | Colorectal Cancer; Metastatic Cancer |
SWOG Cancer Research Network |
2006-11 | PHASE2 |
| NCT00025337 | COMPLETED | Adenocarcinoma of the Colon; Adenocarcinoma of the Rectum; Recurrent Colon Cancer; Recurrent Rectal Cancer; Stage III Colon Cancer; Stage III Rectal Cancer; Stage IV Colon Cancer; Stage IV Rectal Cancer |
National Cancer Institute (NCI) |
2001-09 | PHASE3 |
| NCT00268151 | TERMINATED | Carcinoma, Non-Small Cell Lung |
University of Louisville |
2005-02 | PHASE1 |
| NCT00056446 | COMPLETED | Colorectal Neoplasms; Colonic Neoplasms; Rectal Neoplasms |
Novartis Pharmaceuticals |
2003-01 | PHASE3 |
| NCT00098982 | COMPLETED | Colorectal Cancer |
European Organisation for Research and Treatment of Cancer - EORTC |
2004-09 | PHASE1 |
| NCT00311610 | COMPLETED | Colorectal Cancer |
Alliance for Clinical Trials in Oncology |
2006-01 | PHASE2 |
| NCT00199797 | COMPLETED | Colorectal Cancer |
Ludwig Institute for Cancer Research |
2005-04-18 | PHASE1 |
| NCT00006094 | COMPLETED | Adenocarcinoma of the Rectum; Stage II Rectal Cancer; Stage III Rectal Cancer |
National Cancer Institute (NCI) |
2000-07 | PHASE1; PHASE2 |
| NCT00086983 | TERMINATED | Unspecified Adult Solid Tumor, Protocol Specific |
National Cancer Institute (NCI) |
2004-05 | PHASE1 |
| NCT00276861 | TERMINATED | Colorectal Cancer |
University of Miami |
2005-09 | PHASE2 |
| NCT00112528 | COMPLETED | Pancreatic Cancer |
Alliance for Clinical Trials in Oncology |
2005-06 | PHASE2 |
| NCT02694718 | COMPLETED | Rectal Cancer |
Hoffmann-La Roche |
2005-03 | PHASE2 |
| NCT00263354 | COMPLETED | Stomach Neoplasms |
Sanofi |
2003-10 | PHASE2 |
| NCT00166465 | COMPLETED | Locally Advanced Unresectable or Stage IV Colorectal Cancer |
Mayo Clinic |
2003-08 | PHASE1; PHASE2 |
| NCT00259363 | TERMINATED | Rectal Neoplasms |
Sanofi |
2002-10 | PHASE1; PHASE2 |
| NCT00093652 | TERMINATED | Esophageal Cancer |
Roswell Park Cancer Institute |
2003-05 | PHASE1; PHASE2 |
| NCT00006473 | COMPLETED | Angioimmunoblastic T-cell Lymphoma; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Nodal Marginal Zone B-cell Lymphoma; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Diffuse Mixed Cell Lymphoma; Recurrent Adult Diffuse Small Cleaved Cell Lymphoma; Recurrent Adult Immunoblastic Large Cell Lymphoma; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Adult T-cell Leukemia/Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Small Lymphocytic Lymphoma; Waldenström Macroglobulinemia |
National Cancer Institute (NCI) |
2000-09 | PHASE2 |
| NCT00066274 | COMPLETED | Colorectal Cancer |
UNICANCER |
2002-07-23 | PHASE2 |
| NCT00250029 | COMPLETED | Colonic Diseases; Cancer |
New Mexico Cancer Research Alliance |
2004-04 | |
| NCT00003594 | COMPLETED | Colorectal Cancer |
Alliance for Clinical Trials in Oncology |
1998-10 | PHASE3 |
| NCT00055822 | COMPLETED | Colorectal Cancer |
The University of Texas Health Science Center at San Antonio |
2002-10 | PHASE1; PHASE2 |
| NCT00070265 | TERMINATED | Liver Metastases; Recurrent Colon Cancer; Recurrent Rectal Cancer; Stage IV Colon Cancer; Stage IV Rectal Cancer |
National Cancer Institute (NCI) |
2003-08 | PHASE2 |
| NCT00004187 | COMPLETED | Colorectal Cancer |
Swiss Cancer Institute |
1999-06 | PHASE1; PHASE2 |
| NCT00065117 | TERMINATED | Colorectal Neoplasms; Metastases, Neoplasm |
AstraZeneca |
2003-09 | PHASE2 |
| NCT00003799 | COMPLETED | Adenocarcinoma of the Rectum; Mucinous Adenocarcinoma of the Rectum; Signet Ring Adenocarcinoma of the Rectum; Stage IIA Rectal Cancer; Stage IIB Rectal Cancer; Stage IIC Rectal Cancer; Stage IIIA Rectal Cancer; Stage IIIB Rectal Cancer; Stage IIIC Rectal Cancer |
National Cancer Institute (NCI) |
1999-05 | PHASE1 |
| NCT00040820 | COMPLETED | Colorectal Cancer |
Roswell Park Cancer Institute |
2002-01 | |
| NCT00782041 | TERMINATED | Uterine Neoplasms |
Sanofi |
2003-01 | PHASE2 |
| NCT00275210 | COMPLETED | Colonic Neoplasms |
Sanofi |
1998-10 | PHASE3 |
| NCT00003287 | COMPLETED | Colorectal Cancer |
European Organisation for Research and Treatment of Cancer - EORTC |
1998-03 | PHASE3 |
| NCT00004203 | COMPLETED | Bladder Cancer; Transitional Cell Cancer of the Renal Pelvis and Ureter |
University of Chicago |
2000-02 | PHASE2 |
| NCT00510107 | UNKNOWN | Stomach Neoplasm; Stage IV; Recurrent |
Gachon University Gil Medical Center |
2007-07 | PHASE2 |
| NCT00275119 | UNKNOWN | Pancreatic Cancer |
GERCOR - Multidisciplinary Oncology Cooperative Group |
2003-11 | PHASE2 |
| NCT00005860 | COMPLETED | Cancer |
Memorial Sloan Kettering Cancer Center |
2000-04 | PHASE1 |
| NCT00025142 | COMPLETED | Colorectal Cancer |
Stanford University |
2001-07 | PHASE2 |
| NCT00001835 | COMPLETED | Kidney Disease; Neoplasm; Neoplasm Metastasis |
National Cancer Institute (NCI) |
1999-09 | PHASE1 |
| NCT00005077 | COMPLETED | Unspecified Adult Solid Tumor, Protocol Specific |
City of Hope Medical Center |
2000-02 | PHASE1 |
| NCT00271271 | COMPLETED | Non Small Cell Lung Cancer |
Sanofi |
2003-06 | PHASE2 |
| NCT00403988 | TERMINATED | Breast Neoplasms |
American University of Beirut Medical Center |
2004-06 | PHASE2 |
| NCT00008281 | UNKNOWN | Colorectal Cancer |
Sanofi |
2000-10 | PHASE3 |
| NCT00072553 | UNKNOWN | Colorectal Cancer |
GERCOR - Multidisciplinary Oncology Cooperative Group |
2003-09 | PHASE2 |
| NCT00075452 | UNKNOWN | Pancreatic Cancer |
GERCOR - Multidisciplinary Oncology Cooperative Group |
2003-11 | PHASE3 |
| NCT00513266 | UNKNOWN | Colorectal Cancer; Metastatic Cancer |
Centre Hospitalier Universitaire Vaudois |
2007-06 | PHASE2 |
| NCT00034619 | COMPLETED | Colorectal Cancer |
Eli Lilly and Company |
PHASE2 | |
| NCT00004243 | COMPLETED | Unspecified Adult Solid Tumor, Protocol Specific |
City of Hope Medical Center |
2000-03 | PHASE1 |
| NCT00261092 | COMPLETED | Pancreatic Neoplasms |
Sanofi |
2005-10 | PHASE2 |
| NCT00192088 | COMPLETED | Advanced Gastric Carcinoma |
Eli Lilly and Company |
2004-05 | PHASE2 |
| NCT00180960 | TERMINATED | Colon Tumors; Rectum Tumors; Appendix Tumors; Peritoneum Tumors; Endocrine Tumors |
Gustave Roussy, Cancer Campus, Grand Paris |
2003-06 | PHASE2 |
| NCT00003260 | UNKNOWN | Colorectal Cancer |
GERCOR - Multidisciplinary Oncology Cooperative Group |
1998-01 | PHASE3 |
| NCT00385021 | TERMINATED | Colorectal Neoplasms |
Southwestern Regional Medical Center |
2006-10 | PHASE2 |
(data from https://clinicaltrials.gov, updated on 2026-09-03)
Check the
Oxaliplatin
product page for in-depth specifications, including solubility, stock solutions, MOA, and working concentrations.
Mechanism and Biochemical Profile
Appendix RUO and cGMP Quality Standards
| Quality Dimension | RUO (Research Use Only) | cGMP (Current Good Manufacturing Practice) |
|---|---|---|
| Clinical Applicability | Prohibited in human clinical trials or medical diagnostics. | Mandatory for human clinical trials (Phase I–III) and therapies. |
| Regulatory Status | Non-regulated grade; exempt from drug manufacturing laws. | Legally enforced by health authorities (e.g., FDA, EMA, NMPA). |
| Facility Environment | Unclassified analytical or research laboratories. | Validated Cleanrooms (ISO Class 5–8) with continuous monitoring. |
| Quality Control | Basic purity and activity testing. | Rigorous safety release testing (Sterility, Endotoxin, Mycoplasma). |
| Process Validation | Basic equipment calibration; no process validation required. | Full qualification (IQ/OQ/PQ) and complete batch records. |
| Quality Assurance | Vendor self-declared without required formal QMS. | Mandatory QA/QC unit, Change Control, CAPA, and vendor audits. |
| Regulatory Impact | High risk of IND rejection if used as a critical raw material. | Required for IND/NDA filings, supported by Drug Master Files (DMF). |
Footnotes
Regulatory Note: Governed by FDA (21 CFR Parts 210/211/312), EMA (EudraLex Vol 4), ICH Guidelines (E6/Q7/Q9/Q10), and compendial standards (USP <71>/<85>/<1043>).
- Oxaliplatin Mechanism of Action: CDC7 Kinase Inhibition in Colorectal Cancer Cell Research
- Oxaliplatin: Selectivity & Specificity
- Oxaliplatin Working Concentration | Cell Culture | Treatment
- Oxaliplatin Solubility in DMSO
- Oxaliplatin Storage
- Oxaliplatin Stability
- Oxaliplatin Combination Database
- Oxaliplatin Molecular Weight
- Oxaliplatin SMILES
- Oxaliplatin CAS Number
- Oxaliplatin Chemical Structure (2D and 3D)
- Oxaliplatin IC50 for Cell-based and Cell-free Assays
- Oxaliplatin Sigma (O9512)? Try a better option.
- Oxaliplatin MedChemExpress (HY-17371)? Try a better option.
- Oxaliplatin Cayman (13106)? Try a better option.
- Oxaliplatin Abmole (M2290)? Try a better option.
- Oxaliplatin Tocris (2623)? Try a better option.
- Oxaliplatin SDS｜MSDS
Note: Technical data last updated: Sep 1, 2026.